Paris: Sanofi has received fast track designation from the US Food and Drug Administration (FDA) for SAR446597, a one-time ...

Brain Magnetic Resonance Images are a very useful tool for the diagnosis of brain diseases and analyse brain changes. The appropriate processing (neuroimaging) can help to identify, measure and ...

Optical coherence tomography is beneficial for measuring visual changes and the impact of comorbidities in MS, NMOSD, and ...

Right now few studies on the presence of ectonucleotidases in the retina are present in the literature, therefore deeper insights into these ectonucleotidases (CD39 and CD73) in mediating purinergic ...

Comorbidities worsen outcomes and optic neuritis-related neurodegeneration in multiple demyelinating disorders, including NMOSD and AQP4-NMOSD.